|LETTER TO THE EDITOR
|Year : 2019 | Volume
| Issue : 3 | Page : 210
Serpiginoid choroiditis, tuberculosis, and sarcoidosis
Beuy Joob1, Viroj Wiwanitkit2
1 Sanitation 1 Medical Academic Center, Bangkok, Thailand
2 Department of Biological Science, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria
|Date of Web Publication||12-Sep-2019|
Dr. Beuy Joob
Sanitation 1 Medical Academic Center, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Joob B, Wiwanitkit V. Serpiginoid choroiditis, tuberculosis, and sarcoidosis. Taiwan J Ophthalmol 2019;9:210
We read the publication on “Serpiginoid choroiditis associated with presumed ocular tuberculosis” with great interest. Wang et al. noted that “The clinical presentation, interferon-gamma release assay test, and clinical response to antituberculosis therapy can support a presumed diagnosis of tubercular uveitis ” and also mentioned for the differential diagnosis for sarcoidosis. We would like to share an idea on this report. First, the case might be tuberculosis, but it can also be the case of sarcoidosis or the concurrence between two conditions. Regarding sarcoidosis, the use of broad-spectrum antimycobacterial can also result in clinical improvement. The positive QuantiFERON-TB Gold test might be either a false positive or a true positive result for tuberculosis, but the infectious site might not be intraocular site (there is no positive confirmation from molecular diagnosis ). Hence, the exact diagnosis of the present case is still inconclusive.
Financial support and sponsorship
Conflicts of interest
The authors declare that there are no conflicts of interests of this paper.
| References|| |
Drake WP, Richmond BW, Oswald-Richter K, Yu C, Isom JM, Worrell JA, et al.
Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2013;30:201-11.